OBJECTIVE: The aim of this study was to establish and evaluate (colour Doppler-) high-resolution-ultrasound (hrUS) and bench-top magnetic resonance imaging (btMRI) as new methods to monitor experimental colitis. MATERIALS AND METHODS: hrUS, btMRI and endoscopy were performed in mice without colitis (n = 15), in mice with acute colitis (n = 14) and in mice with acute colitis and simultaneous treatment with infliximab (n = 19). RESULTS: Determination of colon wall thickness using hrUS (32 MHz) and measurement of the cross-sectional colonic areas by btMRI allowed discrimination between the treatment groups (mean a vs. b vs. c - btMRI: 922 vs. 2051 vs. 1472 pixel, hrUS: 0.26 vs. 0.45 vs. 0.31 mm). btMRI, endoscopy, hrUS and colour Doppler-hrUS correlated to histological scoring (p < 0.05), while endoscopy and btMRI correlated to post-mortem colon length (p < 0.05). CONCLUSIONS: The innovative in vivo techniques btMRI and hrUS are safe and technically feasible. They differentiate between distinct grades of colitis in an experimental setting, and correlate with established post-mortem parameters. In addition to endoscopic procedures, these techniques provide information regarding colon wall thickness and perfusion. Depending on the availability of these techniques, their application increases the value of in vivo monitoring in experimental acute colitis in small rodents. KEY POINTS: • Improved in vivo monitoring might balance interindividual differences in murine colitis. • In monitoring murine colitis, btMRI and hrUS are safe and technically feasible. • Very short examination times underline the usefulness especially of hrUS. • Results of btMRI and hrUS correlate with endoscopic and post-mortem findings.
OBJECTIVE: The aim of this study was to establish and evaluate (colour Doppler-) high-resolution-ultrasound (hrUS) and bench-top magnetic resonance imaging (btMRI) as new methods to monitor experimental colitis. MATERIALS AND METHODS: hrUS, btMRI and endoscopy were performed in mice without colitis (n = 15), in mice with acute colitis (n = 14) and in mice with acute colitis and simultaneous treatment with infliximab (n = 19). RESULTS: Determination of colon wall thickness using hrUS (32 MHz) and measurement of the cross-sectional colonic areas by btMRI allowed discrimination between the treatment groups (mean a vs. b vs. c - btMRI: 922 vs. 2051 vs. 1472 pixel, hrUS: 0.26 vs. 0.45 vs. 0.31 mm). btMRI, endoscopy, hrUS and colour Doppler-hrUS correlated to histological scoring (p < 0.05), while endoscopy and btMRI correlated to post-mortem colon length (p < 0.05). CONCLUSIONS: The innovative in vivo techniques btMRI and hrUS are safe and technically feasible. They differentiate between distinct grades of colitis in an experimental setting, and correlate with established post-mortem parameters. In addition to endoscopic procedures, these techniques provide information regarding colon wall thickness and perfusion. Depending on the availability of these techniques, their application increases the value of in vivo monitoring in experimental acute colitis in small rodents. KEY POINTS: • Improved in vivo monitoring might balance interindividual differences in murinecolitis. • In monitoring murinecolitis, btMRI and hrUS are safe and technically feasible. • Very short examination times underline the usefulness especially of hrUS. • Results of btMRI and hrUS correlate with endoscopic and post-mortem findings.
Authors: Christopher Bachmann; Alexander L Klibanov; Timothy S Olson; Jason R Sonnenschein; Jesus Rivera-Nieves; Fabio Cominelli; Klaus F Ley; Jonathan R Lindner; Theresa T Pizarro Journal: Gastroenterology Date: 2006-01 Impact factor: 22.682
Authors: Markus F Neurath; Nadine Wittkopf; Alexandra Wlodarski; Maximilian Waldner; Clemens Neufert; Stefan Wirtz; Claudia Günther; Christoph Becker Journal: Gastroenterology Date: 2010-10-16 Impact factor: 22.682
Authors: Andreas Pohlmann; Lorna C Tilling; Alison Robinson; Olga Woolmer; Scott McCleary; Laurens Kruidenier; Linda C Warnock; Huw D Lewis; Anthony R Hobson; Michael F James Journal: Inflamm Bowel Dis Date: 2009-04 Impact factor: 5.325
Authors: Huaijun Wang; Steven Machtaler; Thierry Bettinger; Amelie M Lutz; Richard Luong; Philippe Bussat; Sanjiv S Gambhir; François Tranquart; Lu Tian; Jürgen K Willmann Journal: Radiology Date: 2013-01-31 Impact factor: 11.105
Authors: Ryan W Stidham; Jingping Xu; Laura A Johnson; Kang Kim; David S Moons; Barbara J McKenna; Jonathan M Rubin; Peter D R Higgins Journal: Gastroenterology Date: 2011-07-23 Impact factor: 22.682
Authors: Stephan Ellmann; Victoria Langer; Nathalie Britzen-Laurent; Kai Hildner; Carina Huber; Philipp Tripal; Lisa Seyler; Maximilian Waldner; Michael Uder; Michael Stürzl; Tobias Bäuerle Journal: PLoS One Date: 2018-10-26 Impact factor: 3.240